Product Images Valganciclovir
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 16 images provide visual information about the product associated with Valganciclovir NDC 59651-444 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - valganciclovir fig1
This appears to be a mathematical formula for calculating two different measures - the Mosteller BSA and the Schwartz Creatinine Clearance. The Mosteller BSA is calculated by multiplying the height of an individual in centimeters with their weight in kilograms, and then dividing the result by 3600. The Schwartz Creatinine Clearance is calculated by dividing the height of an individual in centimeters by their serum creatinine levels in milligrams per deciliter, and then subtracting 2. However, it's difficult to determine the accuracy of this information without a more complete understanding of the context and purpose of these calculations.*
Figure 9 - valganciclovir fig10
Figure 10 - valganciclovir fig11
Figure 11 - valganciclovir fig12
Figure 12 - valganciclovir fig13
package label principal display panel container label - valganciclovir fig14
Valganciclovir for Oral Solution is a medication that comes in a 100 mL bottle which contains 50 mg valganciclovir per mL. The constituted oral solution should be used within 4 hours of preparation and stored under refrigeration. It is important to use valganciclovir as directed by a doctor. The medication comes with a package insert that has more information about the dosage. This product is distributed by Aurobindo Pharma and was made in India.*
package label principal display panel carton label - valganciclovir fig15
This is a description of Valganciclovir for Oral Solution with an NDC number of 59651-444-01. It is only available by prescription. The package contains a new oral dispenser and each mL of the oral solution contains 50 mg of valganciclovir free base. The text provides instructions for the pharmacist and dosage information for patients. The image quality is not clear.*
Figure 1 - valganciclovir fig2
The text describes an oral dispenser with child-resistant properties including a bottle adapter. A figure is referenced as "Figure 1".*
Figure 2 - valganciclovir fig3
Figure 3 - valganciclovir fig4
Figure 4 - valganciclovir fig5
Not available.*
Figure 5 - valganciclovir fig6
Figure 6 - valganciclovir fig7
Figure 7 - valganciclovir fig8
Figure 8 - valganciclovir fig9
Chemical Structure - valganciclovir str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.